AMGEN Inc [AMGN] Stock trading around $271.69 per share: What’s Next?

AMGEN Inc [NASDAQ: AMGN] surged by $9.41 during the normal trading session on while it closed the day at $271.69.

AMGEN Inc stock has also loss -0.13% of its value over the past 7 days. However, AMGN stock has declined by -8.51% in the 3 months of the year. Over the past six months meanwhile, it has lost -15.57% and gained 4.24% year-on date.

The market cap for AMGN stock reached $146.09 billion, with 537.70 million shares outstanding and 536.56 million shares in the current float. Compared to the average trading volume of 3.16M shares, AMGN reached a trading volume of 3994164 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about AMGEN Inc [AMGN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMGN shares is $312.39 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMGN stock is a recommendation set at 2.36. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Cantor Fitzgerald have made an estimate for AMGEN Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 22, 2025. While these analysts kept the previous recommendation, BofA Securities raised their target price to Underperform. The new note on the price target was released on December 10, 2024, representing the official price target for AMGEN Inc stock.

The Average True Range (ATR) for AMGEN Inc is set at 9.18, with the Price to Sales ratio for AMGN stock in the period of the last 12 months amounting to 4.31. The Price to Book ratio for the last quarter was 23.54, with the Price to Cash per share for the same quarter was set at 16.38. Price to Free Cash Flow for AMGN in the course of the last twelve months was 13.38 with Quick ratio for the last quarter at 0.88.

AMGN stock trade performance evaluation

AMGEN Inc [AMGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.13. With this latest performance, AMGN shares dropped by -8.00% in over the last four-week period, additionally sinking by -15.57% over the last 6 months – not to mention a drop of -11.92% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMGN stock in for the last two-week period is set at 43.78, with the RSI for the last a single of trading hit 45.34, and the three-weeks RSI is set at 43.57 for AMGEN Inc [AMGN]. The present Moving Average for the last 50 days of trading for this stock 294.36, while it was recorded at 269.01 for the last single week of trading, and 300.91 for the last 200 days.

AMGEN Inc [AMGN]: An insightful look at the core fundamentals

AMGEN Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.88 and a Current Ratio set at 1.17.

Earnings per share (EPS) analysis for AMGEN Inc [AMGN] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for AMGEN Inc go to 4.28%.

AMGEN Inc [AMGN]: Institutional Ownership

The top three institutional holders of AMGN stocks are: VANGUARD GROUP INC with ownership of 51.87 million shares, which is approximately 9.6598%. BLACKROCK INC., holding 46.04 million shares of the stock with an approximate value of $$14.39 billion in AMGN stocks shares; and BLACKROCK INC., currently with $$9.05 billion in AMGN stock with ownership which is approximately 5.3951%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.